VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 26 filers reported holding VASCULAR BIOGENICS LTD in Q2 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | – | 0 | – | 0.00% | – |
Q4 2020 | $0 | – | 0 | – | 0.00% | – |
Q3 2020 | $0 | – | 0 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q4 2018 | $1,000 | 0.0% | 850 | 0.0% | 0.00% | – |
Q3 2018 | $1,000 | -50.0% | 850 | 0.0% | 0.00% | – |
Q2 2018 | $2,000 | -98.6% | 850 | -95.7% | 0.00% | -100.0% |
Q1 2018 | $139,000 | 0.0% | 19,567 | 0.0% | 0.01% | 0.0% |
Q4 2017 | $139,000 | +414.8% | 19,567 | +339.7% | 0.01% | +500.0% |
Q3 2017 | $27,000 | -3.6% | 4,450 | -29.9% | 0.00% | 0.0% |
Q2 2017 | $28,000 | -49.1% | 6,350 | -36.5% | 0.00% | -50.0% |
Q1 2017 | $55,000 | -57.4% | 10,000 | -62.3% | 0.00% | -66.7% |
Q4 2016 | $129,000 | -20.4% | 26,550 | -14.4% | 0.01% | -25.0% |
Q3 2016 | $162,000 | -12.4% | 31,000 | -22.7% | 0.01% | -20.0% |
Q2 2016 | $185,000 | +302.2% | 40,100 | +360.9% | 0.01% | +233.3% |
Q4 2015 | $46,000 | – | 8,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lion Point Capital, LP | 2,593,286 | $4,382,000 | 1.02% |
Telemetry Investments, L.L.C. | 75,000 | $127,000 | 0.20% |
Ikarian Capital, LLC | 830,747 | $1,404,000 | 0.18% |
DLD Asset Management, LP | 550,000 | $930,000 | 0.06% |
Phoenix Holdings Ltd. | 1,020,000 | $1,724,000 | 0.03% |
Spectrum Planning & Advisory Services Inc. | 16,000 | $27,000 | 0.02% |
BOOTHBAY FUND MANAGEMENT, LLC | 79,716 | $135,000 | 0.00% |
HBK Sorce Advisory LLC | 22,325 | $38,000 | 0.00% |
B. Riley Wealth Management, Inc. | 12,000 | $20,000 | 0.00% |
TWO SIGMA SECURITIES, LLC | 12,155 | $21,000 | 0.00% |